U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT06855355) titled 'CBM588 Reduces Colorectal Polyp Recurrence' on Feb. 11.
Brief Summary: The goal of this randomized crossover clinical trial is to evaluate the efficacy of Clostridium butyricum MIYAIRI 588 (CBM588) in reducing colorectal adenomatous polyp recurrence in adult patients with a history of colorectal polyps.
The main questions it aims to answer are:
* Does CBM588 reduce the recurrence of colorectal adenomatous polyps?
* Does CBM588 lead to a sustained decrease in polyp burden over time? Researchers will compare a group receiving CBM588 in the first year to a group receiving CBM588 in the second year (after a washout period) to determi...